AMWL Amwell
Price Chart
Executive Summary
Amwell announced results from a large NIH-funded randomized trial published in Nature Human Behaviour, showing SilverCloud digital behavioral health reduced mental disorder prevalence by 3.8% at two years with 74.4% participation compared to 30.2% for traditional care. This strong clinical validation strengthens Amwell's positioning in the digital mental health market.
Actionable Insight
The study provides strong clinical evidence that could drive adoption of SilverCloud by health plans and employers. While near-term revenue impact is modest, this validates the product differentiation. Monitor for partnership announcements and potential acceleration in contract wins.
Key Facts
- Study published in Nature Human Behaviour, one of the largest independent trials of its kind, involving 6,205 students across 26 U.S. colleges.
- Students offered SilverCloud had 74.4% participation vs. 30.2% for traditional behavioral health solutions.
- 3.8% lower prevalence of any mental disorder at two years for those receiving digital behavioral healthcare compared to screening and referral.
- Potential up to $1.18 million in avoided mental health-related costs within the study sample.
- Positive impact consistent across minoritized students and those experiencing financial stress.
Financial Impact
The study suggests up to $1.18M in avoided mental health costs within the sample, but the overall revenue impact for Amwell is indirect and depends on commercialization.
Risk Factors
- Competitive digital mental health market with many alternatives (e.g., Teladoc, Headspace).
- Slow adoption cycles in healthcare and uncertainty in reimbursement.
- Study was funded by NIH and independent; commercial replication may vary.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296495 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
today
|
DEFA14A
| $8.84 awaiting T+1 | awaiting T+1 | — | $8.75 (−1.02%) |
|
Jun 3, 2026
6d ago
|
Insider Cluster
| $8.65 $8.53 | ▼ −1.39% | ▲ +1.21% | $8.75 (+1.14%) |
|
Jun 1, 2026
8d ago
|
144
| $8.35 $8.18 | ▼ −2.04% | ▼ −1.31% | $8.75 (+4.78%) |
|
May 18, 2026
22d ago
|
Press Release
| $7.60 $7.71 | ▲ +1.45% | ▲ +2.10% | $8.75 (+15.12%) |
|
May 12, 2026
28d ago
|
8-K
| $7.69 $7.53 | ▼ −2.08% | ▼ −2.66% | $8.75 (+13.77%) |
|
May 5, 2026
5w ago
|
8-K
| $6.99 $7.58 | ▲ +8.44% | ▲ +8.77% | $8.75 (+25.16%) |
|
Apr 23, 2026
6w ago
|
DEFA14A
| $5.95 $5.80 | ▼ −2.52% | ▼ −3.31% | $8.75 (+47.03%) |
|
Mar 2, 2026
14w ago
|
Insider Cluster
| $5.28 $5.14 | ▲ +2.65% | ▲ +1.74% | $8.75 (−65.69%) |
|
Mar 2, 2026
14w ago
|
Insider Cluster
| $5.28 $5.14 | ▼ −2.65% | ▼ −1.74% | $8.75 (+65.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access